CJC-1295 in Ŭnch’ŏn-ŭp — GHRH Analog Research Guide
CJC-1295 research guide for Ŭnch’ŏn-ŭp. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
CJC-1295 isn't found on pharmacy shelves in Ŭnch’ŏn-ŭp or most other cities — this is a specialist compound available through a dedicated online market. The practical advantage of this online-only market is that serious vendors differentiate entirely through their analytical documentation, giving researchers access to better quality signals than local retail ever could. A properly operating CJC-1295 supplier's COA should include HPLC purity, mass spectrometry confirmation of molecular identity, bacterial endotoxin testing, and a residual solvents panel — all traceable to your specific batch. This guide walks Ŭnch’ŏn-ŭp researchers through that evaluation process and explains what quality documentation for CJC-1295 should look like.
Understanding CJC-1295 — Biology & Evidence
The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Ŭnch’ŏn-ŭp researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.
How to Source CJC-1295 — Vendor Guide
Vetting CJC-1295 vendors begins with the COA: request the batch-specific certificate prior to buying, not after. Endotoxin testing in the COA is essential for any injectable research use — endotoxins from bacterial cell wall components can trigger serious immune reactions even at very low concentrations. The combination of community consensus and independent COA review is the most effective quality filter — community feedback surfaces systemic problems invisible in one transaction, and vice versa. The dry lyophilised powder of CJC-1295 is much more stable than liquid pre-made solutions — lyophilised powder stays viable for years at −20°C, while liquid preparations lose activity within weeks.
Order CJC-1295 — ships to Ŭnch’ŏn-ŭp
COA-verified · International tracking · Research grade
CJC-1295 is supplied strictly for research applications and is not approved for human use by the FDA or equivalent regulatory bodies — all information here is for educational purposes only. Storage requirements for CJC-1295: lyophilised powder at −20°C, reconstituted solution kept at 2-8°C refrigerated and used within 30 days; reconstitute only with sterile bacteriostatic water. Verify the endotoxin level in your CJC-1295 batch COA before any injectable research application — look for results stated as EU/mg and confirm they fall within appropriate thresholds. For any individual considering CJC-1295 outside a formal research context: consult a qualified physician — this compound is not approved for human use and its safety characterisation does not match that of regulated drugs.
Frequently Asked Questions
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
